Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InVivo Therapeutics Holdings Corp.

www.invivotherapeutics.com

Latest From InVivo Therapeutics Holdings Corp.

Inside The Spinal Cord: InVivo Therapeutics Looks To Reverse Injury, Leverage Regulatory Reforms

InVivo Therapeutics is looking to build on a breakthrough in understanding the pathophysiology of spinal cord injury to bring the first device to market for partially reversing the debilitating condition. The firm is dealing with a cautious FDA in its pivotal-trial development, but also looking to leverage a new US policy for humanitarian-use devices to expedite its path to market expansion.

Neurology Innovation

Execs On The Move, September 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Medtech Execs On The Move, August 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device

Medtech Execs On The Move, March 2015

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Wound Healing & Tissue Repair
  • Alias(es)
  • InVivo Therapeutics Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • InVivo Therapeutics Holdings Corp.
  • Senior Management
  • Richard Toselli, MD, Acting CEO
    Steven McAllister, CFO
    Thomas R Ulrich, MD, CSO
    Christopher McNulty, SVP, Bus. Dev. & Investor Relations
    Pamela Stahl, Chief Commercial Officer
  • Contact Info
  • InVivo Therapeutics Holdings Corp.
    Phone: (617) 863-5500
    One Kendall Sq., Bldg. 1400 East, Fl. 4
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register